Introduction

The aging population is accelerating rapidly. As of the end of 2017, there were 241 million people aged 60 and older in China, accounting for 17.3% of the total population [1]. Age, is an important risk factor for cancer, as extended lifespan is often accompanied by increased exposure to carcinogenic factors and the prolonged accumulation of genetic changes [2]. Gastric and colorectal cancers are common worldwide, respectively, ranking the third and fifth in terms of incidence but the second and third in terms of mortality, as reported in Global Cancer Statistics 2018 [3]. In China, a large proportion of new cancer cases are diagnosed at age 60 years and older [4], with age-related declines in the immunity system [5], organs function, and physical performance [6], thus posing a challenge to promote patients’ recovery and reduce their adverse clinical outcomes.

Frailty, the most problematic aspect of population aging [7], refers to the state of increased vulnerability for the development of increased dependency and/or death when being exposed to stressors [8]. As per previous studies, it can be observed that frailty is an important risk factor for the prediction of postoperative complications [9], readmission [10], and mortality [11] in cancer patients who accepted surgery. For those older cancer patients, the internal complicated biological changes of aging, together with immune senescence, inflammation, age-related chronic diseases, and external environmental and psychosocial factors, can have an impact on the development of individual malignancies, as well as on the patients’ physiological reserves and vulnerability [12]. Besides, frailty was also significantly associated with worse long-term health-related quality of life in older patients with breast cancer [13]. As we all know, both cancer itself and cancer treatments can be significant additional stressors that challenge the physiological reserves of older patients, all of which could increase the risk of frailty. It is also challenging for clinical staff to decide the optimum treatment for older patients who are heterogeneous in terms of comorbidities, disability, physical reserves, and geriatric conditions [14]. Therefore, the geriatric frailty assessment should be applied to provide an appropriate surgical risk assessment for clinical staff to help guide cancer treatments.

Although there is no golden standard for the assessment of frailty [15], several common frailty assessment tools have been used in clinical practices. The comprehensive geriatric assessment (CGA) is a systematic procedure for the detection of vulnerability in elderly cancer patients, focusing on functional, somatic, and psychosocial domains [14]. Nevertheless, conducting CGA is time-consuming [14] and may not be feasible in an oncology ward with limited resources. The Groningen Frailty Indicator (GFI), originally developed by Steverink et al. [16], is a frailty screening tool with good predictive performance [17], and it has been widely used for screening frailty in cancer patients. Recently, Xiang et al. [18] has translated the GFI into Chinese, and the Chinese version of GFI displays good internal consistency (Cronbach’s α = 0.712), excellent test–retest reliability (ICC = 0.939), and satisfactory criterion validity (AUC = 0.823) among Chinese nursing home residents.

Compared with Western countries, research in the field of frailty started at a later stage in China and mainly focused on older community dwellers [19]. It has been reported in recent studies that the prevalence of frailty among Chinese community residents aged 60 and older, with the results ranging from 38.6 to 60.5% based on the GFI criterion [18, 20]. A meta-analysis by He et al. [21] showed that being female, increasing age, ADL disability, and developing three or more chronic diseases were risk factors for frailty in older community dwellers. However, to our best knowledge, little is known about the prevalence of frailty in Chinese cancer patients, nor the risk factors of frailty. Therefore, the aim of this study was to investigate the prevalence of preoperative frailty in elderly inpatients with gastric and colorectal cancer and to further explore the factors that were associated with frailty in this population.

Material and methods

Study design and participants

The patients who successfully underwent surgery participated in this cross-sectional study, and they were all consecutively recruited from the First Affiliated Hospital of Anhui Medical University (Anhui province, China) from Mar. 2020 to Nov. 2020. The inclusion criteria were as follows: (1) diagnosed with gastric or colorectal cancer; (2) ≥ 60 years old; (3) had normal upper and lower limbs mobility; and (4) signed an informed consent. The exclusion criteria were as follows: (1) with precancerosis, mesothelioma, or benign lesions by postoperative histopathology; (2) recurrence of gastric/colorectal cancer or tumor metastasis; (3) admission for acute intestinal obstruction/gastrointestinal hemorrhage; and (4) with poor cardio-pulmonary function or severe infection/inflammation within 1 month.

Ethical considerations

Ethical approval was granted by the Clinical Medical Research Ethics Committee of the First Affiliated Hospital of Anhui Medical University (No. PJ2020-03–29). This study conformed to the standards of the Declaration of Helsinki and was registered with the Chinese Clinical Trial Registry (No. ChiCTR2000031250).

Laboratory parameters

After a 12-h overnight fast, all patients’ preoperative venous blood samples, including plasma protein (prealbumin, PA; albumin, ALB; globulin, GLO; total protein, TP), blood routine (white blood cell, WBC; red blood cell, RBC; hemoglobin, HGB; reticulocyte, RET; lymphocyte, LYMPH), and tumor markers (alpha-fetoprotein, AFP; carcino-embryonic antigen, CEA; carbohydrate antigen 125, CA125; carbohydrate antigen 19–9, CA19-9; carbohydrate antigen 72–4, CA72-4), were collected together in the morning. Plasma protein, blood routine, and tumor markers were detected with an automatic chemistry analyzer (Cobas 8000, Roche, Germany), an automatic blood analyzer (XN-9000, Sysmex, Japan), and an automatic electrochemiluminescence immunoassay analyzer (Cobas 6000, Roche, Germany), respectively. Tumor stage, area, and histological grade were also collected after finishing surgery.

Demographic and clinical characteristics

A self-designed questionnaire that included sex, age, body mass index (BMI), educational degree, marriage status, smoking/drinking history, past medical history, regular exercise habit, preoperative chemoradiotherapy, cancer type, and blood transfusion before or after surgery, was used to collect the general demographic and clinical data of all patients. Regular exercise habit was defined as participants who did at least 30 min of moderate-intensity exercise (e.g., jogging and brisk walking) per time, with no less than 5 times per week. Smoking/drinking history was defined as the patients who are currently smoking cigarettes/drinking alcohol, or they used to smoke cigarettes/drink alcohol, but they are now abstaining from smoking cigarettes/drinking alcohol.

GFI questionnaire

Frailty was assessed with the self-report version of GFI that has been revised by Peters et al. [22], and it contains 15 items on physical, cognitive, social, and psychological domains. The answer to each item has a score of either 0 or 1, with 1 indicating a dependent problem. The total score of GFI ranges from 0 to 15, and higher scores indicate greater frailty. The cut-off value of GFI ≥ 3 was considered frail in geriatric oncology [17]. The GFI was proved to show moderate internal consistency (Cronbach’s α ranged from 0.68 to 0.712) [18, 22]. All patients filled out the GFI questionnaires within 3 days of their hospital admission for surgery. All items in the revised and Chinese versions of GFI were shown in the Appendix.

Short-Form Mini-Nutritional Assessment (MNA-SF) questionnaire

The MNA-SF, revised by Rubenstein et al. [23] based on the Mini-Nutritional Assessment, is a validated tool to screen malnourished hospitalized patients. The sensitivity, specificity, and diagnostic accuracy of MNA-SF for the prediction of malnutrition were 97.9%, 100%, and 98.7%, respectively [23]. It contains 6 items, namely, weight loss, BMI, stress or illness, mobility, dementia or depression, and loss of appetite. The total score of MNA-SF ranges from 0 to 14, with the score > 11 (≤11) being well-nourished (at risk of malnutrition or malnutrition). The trained researchers routinely obtained patients’ MNA-SF scores within 3 days of their hospital admission for surgery.

Handgrip strength

Preoperative handgrip strength was measured in kilograms (kg) with a handheld dynamometer based on the digital strain gauge sensors (Jamar® Plus + , Performance Health Supply, Inc., Cedarburg, WI, USA). Measurements were conducted with the patients seated, shoulders adducted and neutrally rotated, elbow in 90° flexion, and the forearm and twist in a neutral position [24]. All patients were asked to squeeze the dynamometer as much as possible with the dominant hand. The test was performed twice with a rest interval of at least 30 s, and the maximum value of the two tests was recorded. If the two results differed over 10%, a third test would be carried out [25]. Low handgrip strength was defined as < 26 kg for male and < 18 kg for female [26].

Four-meter walk test

Preoperative walking speed was carried out by means of a 4-m walk test, adding 2 m at the beginning and the end of the walkway, which was provided for acceleration or deceleration [27]. Patients in standing still position were asked to walk at their usual pace (normal gait speed) with or without using auxiliary aids (e.g., canes and walkers). Walking time was recorded by trained researchers using a digital stopwatch (PS-60, China) from the moment that the patient’s first foot crossed the 2-m line until the moment that the patient’s first foot completely crossed the 6-m line. The test was performed twice, and the shortest time was applied for analysis. Slow gait speed was defined as ≤ 0.8 m/s [26].

Mid-upper arm circumference (MUAC) and calf circumference (CC)

Preoperative MUAC and CC were measured to the nearest 0.1 cm with a non-elastic tape (Deli, China) without compressing the subcutaneous tissue. MUAC was measured at the mid-point around the arm between the acromion and the ulnar olecranon, with the patient’s upper limbs in a state of natural hanging [28]. CC was measured around the widest part of the calf, with the patients standing with their legs shoulder-width apart [28].

Statistical analysis

The Kolmogorov–Smirnov test was conducted to verify the normal distribution of continuous variables. All data were expressed as mean ± standard deviation, or median and inter-quartile range, or frequency numbers (percentages). Differences in demographic and clinical characteristics and biochemical laboratory parameters data between frail and non-frail patients were tested using two independent-samples t test or non-parametric test. To determine the risk factors that were associated with frailty, and to estimate their 95% confidence intervals (CI), independent variables with a P value < 0.05 (set at a stringent level) on univariate analysis as described above were entered into a multivariate logistic regression model analysis by adopting the Forward LR method. Data analyses were performed with SPSS 23.0 software package (IBM, Armonk, NY, USA). A two-tailed P value < 0.05 was considered statistically significant.

Results

Demographic and clinical characteristics in all patients

Overall, 330 (100%) patients from the general surgery ward signed the informed consent and were all successfully screened for frailty. Among them, a total of 65 (19.7%) patients were excluded for poor cardiac function/tumor metastasis by MRI/CT (n = 12), refusing/waiting for surgery (n = 25), performing exploratory laparotomy without successfully resecting tumor (n = 10), and nonmalignant tumor/diffuse large B cell lymphoma by postoperative histopathology (n = 18). Hence, 265 (80.3%) patients were included in the final analysis, with 116 (43.8%) in the frail group and 149 (56.2%) in the non-frail group. The detailed process of recruiting subjects was shown in Fig. 1.

Fig. 1
figure 1

Flowchart of the study process

As seen in Table 1, when compared with the non-frail group, the frail group tended to be older and contained more females (less males) (P < 0.05). MUAC, CC, 4-m gait speed (Slow gait speed: 24.1% vs. 8.7%), handgrip strength (Low strength: 31.9% vs. 5.4%), and MNA-SF score (Low score: 91.4% vs. 47.7%) were significantly lower in the frail group than that in the non-frail group (P < 0.05). The frail group had significantly less regular exercise habits (79.3% vs. 92.6%) and more blood transfusion before or after surgery (23.3% vs. 12.1%) compared with the non-frail group (P < 0.05). However, no significant differences in BMI, educational degree, marriage status, smoking/drinking history, Charlson comorbidity index, and preoperative chemoradiotherapy were found between the two groups of subjects (P > 0.05).

Table 1 Subjects’ demographic and clinical characteristics

Biochemical laboratory parameters in all patients

The comparisons of biochemical laboratory parameters between the two groups were presented in Table 2. HGB, PA, and ALB were significantly lower in the frail group than that in the non-frail group (P < 0.05), while the tumor area was significantly higher in the frail group than that in the non-frail group (P < 0.05). However, no significant differences in WBC, RBC, RET, LYMPH, GLO, TP, AFP, CEA, CA125, CA19-9, CA72-4, cancer type, T stage, N stage, M stage, histological grade, and signet ring cells on histological examination were discovered between the two groups of subjects (P > 0.05).

Table 2 Subjects’ biochemical laboratory parameters

Description of variable assignment

The assignment of the dependent variable and significant independent variables was described in Table 3.

Table 3 Description of variable assignment

Risk factors of frailty in patients with gastric and colorectal cancer

The multivariate logistic regression analysis showed that older age (OR = 1.065, 95% CI: 1.001–1.132, P = 0.045), low handgrip strength (OR = 4.346, 95% CI: 1.739–10.863, P = 0.002), no regular exercise habit (OR = 3.228, 95% CI: 1.230–8.469, P = 0.017), and low MNA-SF score (at risk of malnutrition or malnutrition) (OR = 11.090, 95% CI: 5.119–24.024, P < 0.001) were identified as risk factors of frailty in inpatients with gastric and colorectal cancer (see Fig. 2).

Fig. 2
figure 2

Logistic regression analysis for risk factors of frailty

Discussion

This study currently investigated the frailty status of elderly inpatients with gastric and colorectal cancer with a GFI instrument and also analyzed its risk factors. The results showed that the prevalence of frailty was 43.8% and that older age, low handgrip strength, no regular exercise habit, and low MNA-SF score were risk factors of frailty.

To date, the prevalence of frailty in cancer patients is inconsistent worldwide. A systematic review has pooled 20 studies evaluating 2,916 older cancer patients mainly from North America and Europe, suggesting that the median prevalence of frailty was 42% [29]. It can be observed that the prevalence of frailty was similar to the results of our study. However, the review also revealed that the prevalence of frailty varies greatly among different studies (range 6–86%) due to the differences in the content and approach of frailty assessment [29]. For cancer patients, cancer itself can be one of the significant additional stressors that challenges patients’ physiologic reserve, and thus the prevalence of frailty in older cancer patients is usually higher [30]. In addition, various cancer types (e.g., urological, colorectal, breast, and lung), assessment instruments (e.g., CGA, phenotype, GFI, FRAIL, and FI), and research sites (e.g., inpatient, outpatient, and general practice) may also contribute to the differences of frailty prevalence in this population [29, 30]. Chinese researchers have reported that the prevalence of frailty among elderly inpatients ranged from 18 to 36.2% [19, 31]. However, the details of specific disease types among inpatients in these studies were unclear. Another Chinese study showed that the prevalence of frailty in gastric cancer patients aged 80 and over was 32.7% based on the three baseline frailty traits, namely, albumin, hematocrit, and creatinine [9]. Given the inconsistent results on the frailty prevalence, and especially higher in cancer patients, clinical staff should promptly assess the frailty status of those people. Subsequently, a series of measures such as personalized exercise, combined with nutrition supplements containing dairy, protein-rich foods, fruits, and nuts, as well as cognitive training, should be taken to reduce the burden of frailty on this population.

Age is an important risk factor of frailty in this study. It has been shown in a systematic review that the risk of frailty in the elderly people increased significantly with the increase of age [21]. As mentioned earlier, older patients experienced much more age-related biological changes, multiple diseases, diseases treatments, and social-psychological factors, all of which may eventually induce the onset of frailty [12]. The aging process can be depicted as a time-dependent decline in physiological organ function, resulting in the development of diseases, including cancer [32]. To a certain extent, the related toxicity of cancer treatments could cause severe impairments in the body function, and some evidences have proved that cancer treatments might be associated with accelerated aging [33]. Considering these facts, aging, cancer, and cancer treatments might interact with the onset of frailty.

Low handgrip strength was identified as an important risk factor of frailty in the present study. Handgrip strength serves as a reliable proxy index of an individual hand motor abilities [34], and measuring handgrip strength is a simple and feasible measure of muscle strength [26]. Xue et al. [35] conducted a prospective cohort study of 352 elderly women and observed that lower baseline handgrip strength was significantly correlated with the higher risk of frailty, which was consistent with our findings. Interestingly, Puts et al. [36] put forward that in newly diagnosed elderly cancer patients, only low grip strength could predict therapeutic toxicity, which may help clinicians gain insight into the effects of cancer treatments. In addition, for older adults of the same age, handgrip strength might be a more important single marker of frailty than chronological age alone [37]. Furthermore, it has been proved to be an effective screening tool for frailty in older patients with newly diagnosed hematological cancer [38]. Based on these facts, we could understand that handgrip strength is closely connected with frailty in both normal individuals and cancer patients.

No regular exercise habit usually meant physical inactivity or being sedentary, and it was significantly associated with frailty in our study. Haider et al. [39] concluded that among community dwellers, performing no regular physical activity was substantially linked with the higher risk of frailty, which was in line with our findings. In addition, da Silva et al. [40] also indicated that among Brazilian older adults, the frailty prevalence increased with physical inactivity combined with excessive time spent in sedentary behavior. Hopefully, accumulating studies [41, 42] give the information that physical activity offers a model of improving the function of dysregulated multiple physiologic systems, thereby preventing or alleviating the progress of frailty.

Low MNA-SF score implied that these patients were at risk of malnutrition or malnutrition, and it was an important risk factor of frailty in the present study. This result was consistent with an earlier study [43], which indicated that low MNA score (at risk of malnutrition/malnutrition) was strongly correlated with frailty (OR = 2.72 and OR = 17.4, respectively) among 6,045 older community residents in Singapore. Recently, Liu et al. [44] showed that poor nutritional status was associated with an increased risk of frailty (OR = 2.66) among 705 Chinese nursing home residents. Meanwhile, Gabrovec et al. [45] also highlighted that malnutrition or being at risk of malnutrition were risk factors of frailty in aging. Nevertheless, Zhang et al. [46] revealed that frailty was significantly associated with the risk of malnutrition (OR = 3.82) in older cancer patients. We speculated that the close connection between frailty and malnutrition in cancer patients might be attributed to share common pathophysiological pathways, including inflammation, reduced body tissue, cognitive disorder, poor physical performance, and pernicious sociodemographic characteristics [47]. Malnutrition is common in older cancer patients and is mostly caused by tumor invasion, side effects of cancer treatments, cachexia, and anorexia of aging. Consequently, there is an urgent need for clinical staff to early identify malnutrition in these patients and then take targeted therapy to improve their nutritional status.

Although we did hope to explore some specific disease-related risk factors of frailty among these elderly cancer patients, the findings of this study only displayed some non-specific common factors in this population. As a result, there are several inevitable limitations in our study. Firstly, we did not detect laboratory biomarkers, as several potential biomarkers that might be involved in the development of frailty. Secondly, this was an observational study and the underlying cellular and molecular mechanisms of frailty were far from being understood, thus necessitating further researches to elucidate this. Thirdly, this study was performed at a single center, and multicenter studies should be conducted soon. Apart from this, the long-term outcomes of cancer patients after surgery such as complications and mortality should also be concerned in the future.

In conclusion, the prevalence of frailty is relatively high among elderly inpatients with gastric and colorectal cancer in this study. Older age, low handgrip strength, no regular exercise habit, and low MNA-SF score are risk factors of frailty. Frailty is emerging as an important determinant for health and the mentioned risk factors should be considered when implementing interventions to improve the health outcomes of frail cancer patients.